INTRAARTICULAR KNEE JOINT INJECTION: HYALURONIC ACID VS POLYNUCLEOTIDES
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
This study is a retrospective work of ambulatorial injections in patients suffering from Class II osteoarthritis (OA) of the knee. The research was conducted from January 2012 to July 2012 in a private clinic in Benevento, Hospital Val D'Els a, Poggibonsi, Siena. A total of 60 patients were treated with intraarticular knee injections. Group A. composed of 30 patients (15 male and 15 female), was treated with injections of low molecular weight Hyaluronic Acid and Group B, composed of 30 patients (15 male and 15 female) was treated with injections of Ploynucleotide. At the six month follow-up, Group B showed statistically significant difference (p<0.05) of the Visual Analogue Scale (VAS); the Knee injury and Osteoarthritis Outcome Score for Group B also showed a statistically significant difference (p<0.05). The results obtained suggest that polynucleotides can be considered as a valid alternative to hyaluronic acid for the treatment of symptomatic osteoarthritis of the knee.
Downloads
Citations
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.